BIO

Brad Crutchfield brings nearly 40 years of experience in developing and commercializing Life Science tools.  Most recently he served as the Chief Commercial Officer of 10x Genomics building the global sales, and support organization that today is 500 FTE’s driving a $500mm+ business. He worked closely with the CEO to support the 2019 IPO. Prior positions, include QIAGEN’s Senior Vice President, Life Sciences business area, Vice President and General Manager, EMEA for Illumina, and positions of increasing responsibility with Bio-Rad Laboratories including 14 years as President of the Life Science Group. Brad currently serves as Chairman of Pixelgen AB and serves of the Boards of Partillion Inc and S2 Genomics, as well as a senior advisor for Alamar Biosciences. He a B.S. in Physiology from the University of California, Davis.